• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors influencing overdose and misuse of gender-affirming medication in Chinese transgender and gender diverse individuals: A qualitative study of experience and perspectives.影响中国跨性别者和性别多样化个体过量使用及滥用性别肯定药物的因素:一项关于经历和观点的定性研究
Int J Transgend Health. 2024 Feb 22;26(3):779-794. doi: 10.1080/26895269.2024.2316693. eCollection 2025.
2
"You Are the Expert of Your Own Experience": A Thematic Analysis of Experiences of Autism and Gender Diversity in Adulthood.“你是自身经历的专家”:成年期自闭症与性别多样性经历的主题分析
Autism Adulthood. 2024 Sep 16;6(3):300-311. doi: 10.1089/aut.2022.0111. eCollection 2024 Sep.
3
A European Network for the Investigation of Gender Incongruence in adolescents.一个调查青少年性别不一致的欧洲网络。
J Sex Med. 2024 Mar 28;21(4):350-356. doi: 10.1093/jsxmed/qdae014.
4
Self-injection experiences among transgender people on injectable gender-affirming hormone therapy: A narrative review.接受注射用性别确认激素治疗的跨性别者的自我注射经历:一项叙述性综述。
J Am Pharm Assoc (2003). 2025 Jul-Aug;65(4):102405. doi: 10.1016/j.japh.2025.102405. Epub 2025 Apr 27.
5
Gender-Affirming Hormone Therapy and Depressive Symptoms Among Transgender Adults.成年跨性别者的性别肯定激素治疗与抑郁症状
JAMA Netw Open. 2025 Mar 3;8(3):e250955. doi: 10.1001/jamanetworkopen.2025.0955.
6
Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.移民健康素养提升干预措施背景下的性别差异:一项定性证据综合分析
Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD013302. doi: 10.1002/14651858.CD013302.pub2.
7
Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based Study.成人性别肯定激素治疗与肾功能变化:一项基于人群的回顾性研究。
Kidney Med. 2025 Jun 17;7(8):101051. doi: 10.1016/j.xkme.2025.101051. eCollection 2025 Aug.
8
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
9
Factors that influence participation in physical activity for people with bipolar disorder: a synthesis of qualitative evidence.影响双相障碍患者参与体育活动的因素:定性证据的综合分析。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013557. doi: 10.1002/14651858.CD013557.pub2.
10
Cost-Effectiveness of an Interdisciplinary, Internet-Based Transgender Health Care Program in Germany: Economic Evaluation Alongside a Randomized Controlled Trial.德国一项基于互联网的跨学科跨性别医疗保健项目的成本效益:与随机对照试验同步进行的经济评估
J Med Internet Res. 2025 Jun 19;27:e66371. doi: 10.2196/66371.

本文引用的文献

1
Intimate Partner Violence and Mental Health Among Transgender and Gender Diverse Young Adults.跨性别和性别多样化的年轻成年人中的亲密伴侣暴力与心理健康
J Fam Violence. 2023 May 27:1-15. doi: 10.1007/s10896-023-00579-7.
2
Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment.葡萄糖稳态、糖尿病与性别肯定治疗。
Biomedicines. 2023 Feb 22;11(3):670. doi: 10.3390/biomedicines11030670.
3
Toward good practice in thematic analysis: Avoiding common problems and be(com)ing a researcher.迈向主题分析的良好实践:避免常见问题并成为一名研究者。
Int J Transgend Health. 2022 Oct 25;24(1):1-6. doi: 10.1080/26895269.2022.2129597. eCollection 2023.
4
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
5
Transgender women of color in the U.S. South: A qualitative study of social determinants of health and healthcare perspectives.美国南部的有色人种跨性别女性:健康的社会决定因素与医疗保健观点的定性研究。
Int J Transgend Health. 2020 Dec 17;23(1-2):164-177. doi: 10.1080/26895269.2020.1848691. eCollection 2022.
6
Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.跨性别和非二元性别青年接受性别肯定护理的心理健康结果。
JAMA Netw Open. 2022 Feb 1;5(2):e220978. doi: 10.1001/jamanetworkopen.2022.0978.
7
The role of androgens in transgender medicine.雄激素在跨性别医学中的作用。
Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101617. doi: 10.1016/j.beem.2022.101617. Epub 2022 Jan 21.
8
The mental health of transgender and gender non-conforming people in China: a systematic review.中国跨性别和性别不一致人群的心理健康:系统评价。
Lancet Public Health. 2021 Dec;6(12):e954-e969. doi: 10.1016/S2468-2667(21)00236-X.
9
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population. transgender 人口中性别肯定激素治疗与心血管风险的关联。
Front Endocrinol (Lausanne). 2021 Sep 30;12:718200. doi: 10.3389/fendo.2021.718200. eCollection 2021.
10
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.向最低有效剂量的醋酸环丙孕酮在跨性别女性:从 ENIGI 研究的结果。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3936-e3945. doi: 10.1210/clinem/dgab427.

影响中国跨性别者和性别多样化个体过量使用及滥用性别肯定药物的因素:一项关于经历和观点的定性研究

Factors influencing overdose and misuse of gender-affirming medication in Chinese transgender and gender diverse individuals: A qualitative study of experience and perspectives.

作者信息

Li Liping, Pan Huiqing, Wang Keling, Yang Muhua, He Ying, Cai Lu, Liu Yang

机构信息

School of Medicine, Xiamen University, Xiamen, China.

School of Medicine, Tongji University, Shanghai, China.

出版信息

Int J Transgend Health. 2024 Feb 22;26(3):779-794. doi: 10.1080/26895269.2024.2316693. eCollection 2025.

DOI:10.1080/26895269.2024.2316693
PMID:40756725
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12312125/
Abstract

BACKGROUND

The overdose and misuse (ODM) of gender-affirming hormone treatment (GAHT) medications is common among the Chinese transgender and gender diverse (TGD) population due to a unique sociocultural and healthcare basis. However, there is no existing publication providing descriptions and interpretations of this situation among Chinese TGD people.

AIMS

To investigate related factors, probable triggers, and causes of GAHT ODM among Chinese TGD people on a qualitative basis, and develop a corresponding framework for further studies.

METHODS

We used an expert panel to draw up the criteria of ODM and semi-structured interviews to collect data. TGD people from mainland China were recruited online for interviews. An inductive thematic analysis was conducted using a framework method. A working analytical framework was developed based on the coding of nine randomly selected transcripts and the researchers' discussion and experience. The framework was continuously refined and applied to code and chart all transcripts into the framework matrix. We examined all potential experiences and perspectives of participants on GAHT ODM.

RESULTS

Twenty-one Chinese TGD youths (mean age 21.6, SD 3.65) with GAHT experience in the past 12 months completed eligible interviews, of whom eight were trans women, eight were trans men and five identified themselves as genderqueer or non-binary. Ten of them reported ODM according to the criteria derived from an expert panel. We extracted five domains consisting of 14 topics related to their GAHT medication behaviors, i.e. accessibility of healthcare resources, gender minority stress, online TGD communities and drug sellers, gender dysphoria and mental distress, and knowledge deficit.

CONCLUSION

This study firstly used qualitative methods to investigate GAHT ODM among Chinese TGD people, providing a framework to identify probable causes and triggers for further studies. Practitioners or psychologists can take this framework as a reference when evaluating TGD clients in order to better understand their behaviors.

摘要

背景

由于独特的社会文化和医疗保健基础,性别肯定激素治疗(GAHT)药物的过量使用和滥用(ODM)在中国跨性别者和性别多样化(TGD)人群中很常见。然而,目前尚无出版物对中国TGD人群中的这种情况进行描述和解读。

目的

定性调查中国TGD人群中GAHT药物过量使用和滥用的相关因素、可能的触发因素和原因,并为进一步研究制定相应框架。

方法

我们使用专家小组制定ODM标准,并通过半结构化访谈收集数据。从中国大陆招募TGD人群进行在线访谈。采用框架法进行归纳主题分析。基于对9份随机抽取的访谈记录的编码以及研究人员的讨论和经验,开发了一个工作分析框架。该框架不断完善,并应用于将所有访谈记录编码并绘制到框架矩阵中。我们研究了参与者对GAHT药物过量使用和滥用的所有潜在经历和观点。

结果

21名在过去12个月内有GAHT经历的中国TGD青年(平均年龄21.6岁,标准差3.65)完成了符合条件的访谈,其中8名是跨性别女性,8名是跨性别男性,5名自我认定为性别酷儿或非二元性别。根据专家小组制定的标准,其中10人报告了药物过量使用和滥用情况。我们提取了五个领域,包括与他们的GAHT药物行为相关的14个主题,即医疗资源的可及性、性别少数群体压力、在线TGD社区和药品卖家、性别焦虑和精神困扰以及知识缺乏。

结论

本研究首次采用定性方法调查中国TGD人群中的GAHT药物过量使用和滥用情况,为识别可能的原因和触发因素提供了一个框架,以便进行进一步研究。从业者或心理学家在评估TGD客户时可以参考这个框架,以便更好地理解他们的行为。